Nfat5与Fzd4 mRNA上调提示新生儿缺氧缺血性脑病不良结局
该研究基于爱尔兰与瑞典两项队列,检测124例新生儿脐带血mRNA表达,发现严重HIE患儿Fzd4 mRNA升高,且Nfat5与Fzd4 mRNA在远期神经发育严重异常患儿中升高,提示其或可作为HIE严重程度的早期客观标志物。
要点
- 严重HIE患儿脐带血Fzd4 mRNA较轻度及中度HIE显著升高。
- Nfat5与Fzd4 mRNA在远期神经发育严重异常患儿中显著升高。
- 上述mRNA或可辅助现有指标早期识别HIE严重程度。
核心结论
- 严重HIE患儿脐带血Fzd4 mRNA表达升高。
- Nfat5 mRNA与Fzd4 mRNA在远期神经发育严重异常患儿中表达升高。
- 这些mRNA或可作为分娩时HIE严重程度的早期客观标志物。
研究设计与样本
- 研究纳入BiHiVE1研究(爱尔兰,2009-2011)与BiHiVE2研究(爱尔兰和瑞典,2013-2015)的婴儿。
- HIE患儿在24小时评估改良Sarnat评分,并随访至18-36个月。
- 采用定量实时聚合酶链反应检测脐带血mRNA表达。
- 共研究124例婴儿,包括对照37例、围产期窒息43例和HIE 44例。
- 神经发育结局分析了56例婴儿。
临床怎么用
- 对疑似HIE新生儿,脐带血Fzd4 mRNA或可辅助早期判断HIE严重程度。
- Nfat5与Fzd4 mRNA或可辅助识别远期神经发育严重异常高风险患儿。
- 上述标志物需结合现有评估手段综合判断,不能单独用于临床决策。
局限性
- 神经发育结局仅分析了56例婴儿,样本量有限。
- 研究为队列观察性设计,未报告多变量校正或独立验证队列结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate umbilical cord messenger RNA (mRNA) expression as biomarkers for the grade of hypoxic-ischemic encephalopathy (HIE) and long-term neurodevelopment outcome. STUDY DESIGN: Infants were recruited from the BiHiVE1 study, Ireland (2009-2011), and the BiHiVE2 study, Ireland, and Sweden (2013-2015). Infants with HIE were assigned modified Sarnat scores at 24 hours and followed at 18-36 months. mRNA expression from cord blood was measured using quantitative real-time polymerase chain reaction. RESULTS: We studied 124 infants (controls, n = 37; perinatal asphyxia, n = 43; and HIE, n = 44). Fzd4 mRNA increased in severe HIE (median relative quantification, 2.98; IQR, 2.23-3.68) vs mild HIE (0.88; IQR, 0.46-1.37; P = .004), and in severe HIE vs moderate HIE (1.06; IQR, 0.81-1.20; P = .003). Fzd4 mRNA also increased in infants eligible for therapeutic hypothermia (1.20; IQR, 0.92-2.37) vs those who were ineligible for therapeutic hypothermia group (0.81; IQR, 0.46-1.53; P = .017). Neurodevelopmental outcome was analyzed for 56 infants. Nfat5 mRNA increased in infants with severely abnormal (1.26; IQR, 1.17-1.39) vs normal outcomes (0.97; IQR, 0.83-1.24; P = .036), and also in infants with severely abnormal vs mildly abnormal outcomes (0.96; IQR, 0.80-1.06; P = .013). Fzd4 mRNA increased in infants with severely abnormal (2.51; IQR, 1.60-3.56) vs normal outcomes (0.74; IQR, 0.48-1.49; P = .004) and in infants with severely abnormal vs mildly abnormal outcomes (0.97; IQR, 0.75-1.34; P = .026). CONCLUSIONS: Increased Fzd4 mRNA expression was observed in cord blood of infants with severe HIE; Nfat5 mRNA and Fzd4 mRNA expression were increased in infants with severely abnormal long-term outcomes. These mRNA may augment current measures as early objective markers of HIE severity at delivery.
引用
- O'Sullivan MP, Casey S, Finder M, et al. Up-Regulation of Nfat5 mRNA and Fzd4 mRNA as a Marker of Poor Outcome in Neonatal Hypoxic-Ischemic Encephalopathy. J Pediatr. 2020. PMID: 32828883. doi:10.1016/j.jpeds.2020.08.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。